In vitro fertilization stimulation protocol for normal responder patients

References

• Penzias AS. Improving results with assisted reproductive technologies: individualized patient-tailored strategies for ovulation induction. Reprod Biomed Online 2004;9:43–46.
   PubMed Web of Science ®Google Scholar
• Loumaye E. The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer. Hum Reprod 1990;5:357–376.
   PubMed Web of Science ®Google Scholar
• Lejeune B, Degueldre M, Camus M, Vekemans M, Opsomer L, Leroy F. In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration. Fertil Steril 1986;45:377–383.
   PubMed Web of Science ®Google Scholar
• Klingmüller D, Schepke M, Enzweiler C, Bidlingmaier F. Hormonal responses to the new potent GnRH antagonist Cetrorelix. Acta Endocrinol 1993;128:15–18.
   PubMedGoogle Scholar
• Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 2002;17:874–885.
   PubMed Web of Science ®Google Scholar
• Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online 2007;14:640–649.
   PubMed Web of Science ®Google Scholar
• Fauser BC, Devroey P. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? Fertil Steril 2005;83:1607–1611.
   PubMed Web of Science ®Google Scholar
• Griesinger G, Felberbaum R, Diedrich K. GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians’ second choice? Data from the German national IVF registry. Hum Reprod 2005;20:2373–2375.
   PubMed Web of Science ®Google Scholar
• Marci R, Caserta D, Dolo V, Tatone C, Pavan A, Moscarini M. GnRH antagonist in IVF poor-responder patients: results of a randomized trial. Reprod Biomed Online 2005;11:189–193.
   PubMed Web of Science ®Google Scholar
• Germond M, Senn A, Reymond O, de Grandi P. Why lose an in vitro fertilization cycle when stimulation fails? Fertil Steril 1990;53:936–938.
   PubMed Web of Science ®Google Scholar
• Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L; ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011;26:1616–1624.
   PubMed Web of Science ®Google Scholar
• Bouchard P, Fauser BC. Gonadotropin-releasing hormone antagonist: new tools vs. old habits. Fertil Steril 2000;73:18–20.
   PubMed Web of Science ®Google Scholar
• European and Middle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Human Reprod 2001;16:644–651.
   PubMed Web of Science ®Google Scholar
• Engel JB, Griesinger G, Schultze-Mosgau A, Felberbaum R, Diedrich K. GnRH agonists and antagonists in assisted reproduction: pregnancy rate. Reprod Biomed Online 2006;13:84–87.
   PubMed Web of Science ®Google Scholar
• Kolibianakis EM, Collins J, Tarlatzis B, Papanikolaou E, Devroey P. Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum Reprod Update 2006;12:3–12.
   PubMed Web of Science ®Google Scholar
• Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, Abou-Setta AM. GnRH antagonists are safer than agonists: an update of a Cochrane review. Hum Reprod Update 2011;17:435.
   PubMed Web of Science ®Google Scholar
• Craft I, Gorgy A, Hill J, Menon D, Podsiadly B. Will GnRH antagonists provide new hope for patients considered ‘difficult responders’ to GnRH agonist protocols? Hum Reprod 1999;14:2959–2962.
   PubMed Web of Science ®Google Scholar
• Nikolettos N, Al-Hasani S, Felberbaum R, Demirel LC, Kupker W, Montzka P, Xia YX et al. Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders. Eur J Obstet Gynecol Reprod Biol 2001;97:202–207.
   PubMed Web of Science ®Google Scholar
• Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Rombauts L, Devroey P. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update 2006;12:333–340.
   PubMed Web of Science ®Google Scholar
• Borm G, Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod 2000;15:1490–1498.
   PubMed Web of Science ®Google Scholar
• Serafini P, Stone B, Kerin J, Batzofin J, Quinn P, Marrs RP. An alternate approach to controlled ovarian hyperstimulation in “poor responders”: pretreatment with a gonadotropin-releasing hormone analog. Fertil Steril 1988;49:90–95.
   PubMed Web of Science ®Google Scholar
• Feldberg D, Farhi J, Ashkenazi J, Dicker D, Shalev J, Ben-Rafael Z. Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril 1994;62:343–346.
   PubMed Web of Science ®Google Scholar
• Meldrum DR, Wisot A, Hamilton F, Gutlay AL, Kempton WF, Huynh D. Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril 1989;51:455–459.
   PubMed Web of Science ®Google Scholar
• Fujii S, Sagara M, Kudo H, Kagiya A, Sato S, Saito Y. A prospective randomized comparison between long and discontinuous-long protocols of gonadotropin-releasing hormone agonist for in vitro fertilization. Fertil Steril 1997;67:1166–1168.
   PubMed Web of Science ®Google Scholar
• Chang PL, Zeitoun KM, Chan LK, Thornton MH 2nd, Sauer MV. GnRH antagonist in older IVF patients. Retrieval rates and clinical outcome. J Reprod Med 2002;47:253–258.
   PubMed Web of Science ®Google Scholar
• Al-Inany H, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev 2001;14:CD001750.
   Google Scholar